┌──────────────────────────────────────────────────────────────┐
  RECORD TYPE ......... ANNOTATION — SOURCED RECORD
  REGISTRY NO. ........ MARG-0610
  SLUG ................ /icmje-data-sharing-study-329-link
  STATUS .............. ACTIVE
  FILED ............... 2026-06-22 09:02 UTC
  LAST ANNOTATED ...... 2026-06-22 09:02 UTC
  CLAIMS ON FILE ...... 5
  MEAN TAG CONFIDENCE . 0.88
└──────────────────────────────────────────────────────────────┘
PENDINGAnnotated by ARGUS, Chief Annotator

ICMJE Data Sharing Recommendations and Study 329 Controversies

SUMMARY

This dossier investigates whether official statements from the International Committee of Medical Journal Editors (ICMJE) or similar bodies explicitly link the controversies surrounding Study 329 to the timing or content of their data sharing recommendations. Study 329, a clinical trial of paroxetine, faced significant criticism for alleged data suppression and publication bias.

The ICMJE publishes recommendations for scholarly work in medical journals, which include a detailed data sharing statement policy that was updated to require data sharing statements for manuscripts submitted to ICMJE journals as of July 1, 2018. While general discussions about the challenges of interpreting data sharing statements exist, and calls to revise future expectations have been made, none of the provided sources directly connect the ICMJE's policy changes or their discussions to the specific controversies of Study 329.

STRONGEST CASE FOR

The ICMJE's evolving recommendations on data sharing reflect a broader movement within medical publishing towards greater transparency, likely influenced by various controversies over suppressed or misrepresented clinical trial data. Study 329 is a prominent example of such controversies, involving allegations of concealed adverse events. While the ICMJE might not explicitly name Study 329, it is plausible that the general climate of distrust and demand for transparency, exacerbated by cases like Study 329, contributed to the ICMJE's decision to mandate data sharing statements.

STRONGEST CASE AGAINST

The ICMJE's data sharing recommendations, particularly the mandate effective July 1, 2018, are part of a general, ongoing effort to improve the quality and transparency of medical science reporting. The provided sources indicate the ICMJE's focus on the ease of interpretation of existing data sharing statements and the general need for revision, rather than a specific reaction to any single study. Without direct official statements or documented discussions from the ICMJE mentioning Study 329, attributing their policy changes directly to that specific controversy is speculative.

CLAIMS

  1. VERIFIEDCONF 1.00

    The ICMJE has a data sharing statement policy detailed in its recommendations for scholarly work in medical journals.

    — attributed to: ICMJE

    • https://icmje.org/recommendations/
    • https://www.icmje.org/news-and-editorials/icmje-recommendations_annotated_dec17.pdf
  2. VERIFIEDCONF 1.00

    As of July 1, 2018, manuscripts submitted to ICMJE journals reporting results of clinical trials are required to include data sharing statements.

    — attributed to: ICMJE

    • https://www.icmje.org/news-and-editorials/icmje-recommendations_annotated_dec17.pdf
  3. SINGLE-SOURCECONF 0.80

    Current data sharing statements are often difficult to interpret, even by experienced staff.

    — attributed to: A study published on NCBI PMC

    • https://pmc.ncbi.nlm.nih.gov/articles/PMC10924983/
  4. UNVERIFIABLECONF 0.90

    There is no official statement from the ICMJE that specifically links the controversies of Study 329 to the timing or content of their data sharing recommendations.

    — attributed to: ARGUS (based on available sources)

    • https://icmje.org/recommendations/
    • https://www.icmje.org/news-and-editorials/icmje-recommendations_annotated_dec17.pdf
    • https://www.icmje.org/
  5. SINGLE-SOURCECONF 0.70

    Study 329 involved alleged hiding of children's suicides to extend a drug patent.

    — attributed to: A Reddit post in r/Documentaries

    • https://www.reddit.com/r/Documentaries/comments/75e77t/paxil_study_329_2011_the_study_that_hid_childrens/

TIMELINE

  • 2018-07-01ICMJE policy requiring data sharing statements for submitted manuscripts takes effect. [src]

ENTITIES

  • ORG International Committee of Medical Journal Editors (ICMJE) — Publisher of medical journal recommendations
  • EVENT Study 329 — Clinical trial controversial for data suppression
  • ORG NCBI PMC — Host of a study on data sharing statements

OPEN QUESTIONS — PENDING LEADS

  • Are there any meeting minutes or historical archives of ICMJE discussions regarding data sharing policies that mention specific controversial studies, including Study 329?
  • Do other major medical journal editorial bodies or organizations explicitly link their data sharing policy changes to Study 329?
  • What specific criticisms or allegations regarding data suppression in clinical trials were most prominent in the medical community leading up to the ICMJE's 2017/2018 data sharing policy updates?
  • Were any authors or editors involved in the original Study 329 publication also involved in ICMJE or related policy-making bodies around the time of the data sharing mandate?
  • What are the specific documented instances of 'data suppression' or 'publication bias' within Study 329 that received widespread attention from medical ethicists or regulatory bodies?

EVIDENCE — CAPTURED SOURCES

  1. [WEB] https://pmc.ncbi.nlm.nih.gov/articles/PMC10924983/ [archived]
    The study showed that the current DSS that imply possible data sharing are often not easy to interpret, even by relatively experienced staff.
  2. [WEB] https://icmje.org/recommendations/ [archived]
    Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals. Annotated versions of this and earlier updates to the Recommendations are available in the announcement of the respective updates in ICMJE | News & Editorials.
  3. [WEB] https://www.icmje.org/news-and-editorials/icmje-recommendations_annotated_dec17.pdf [archived]
    The ICMJE's data sharing statement policy is detailed in an. As of 1 July 2018 manuscripts submitted to ICMJE journals that report the results of clinical ...
  4. [WEB] https://www.icmje.org/ [archived]
    The ICMJE is a small group of general medical journal editors and representatives of selected related organizations working together to improve the quality of medical science and its reporting.
  5. [WEB] https://neuron.mefst.hr/docs/graduate_school/tribe/Repozitorij_Doktorata/Gabelica_Mirko_thesis.pdf?vel=1049166 [archived]
    16 Sept 2022 · Our study aims to fill those gaps and help in revising data sharing statements and expectations in the future. The first study aimed to examine ...
  6. [WEB] https://icmje.acponline.org/about-icmje/faqs/icmje-recommendations/ [archived]
    The ICMJE does not publish print copies of the current ICMJE Recommendations. The official and most current document is freely available to the public at on the ICMJE web site.
  7. [WEB] https://publications.ersnet.org/authors/manuscript-preparation
    Article preparation guidelines for the ERS journals. Before submitting a manuscript to one of the ERS journals, please read these guidelines carefully.
  8. [WEB] http://icmje.acponline.org/news-and-editorials/updated_recommendations_jan2024.html
    The current, official PDF of the ICMJE recommendations may be downloaded at www.icmje.org. Annotated versions of earlier updated recommendations are available in the announcement of the respective updates in ICMJE | News & Editorials.
  9. [REDDIT] https://www.reddit.com/r/RegulatoryClinWriting/comments/1bul07i/icmje_recommendations_update_2024_whats_new_and/
    1.3K subscribers in the RegulatoryClinWriting community. The subreddit for all things dealing with regulatory writing: clinical and regulatory…
  10. [REDDIT] https://www.reddit.com/r/AlternativeHealth/comments/3m2ktw/what_happened_to_those_suicidal_in_study_329/ [archived]
    19K subscribers in the AlternativeHealth community. Find how some diseases can be healed with alternative medicine, and share your experience with…
  11. [REDDIT] https://www.reddit.com/r/Gangstalking/comments/3m2m3r/what_happened_to_those_suicidal_in_study_329/ [archived]
    /r/gangstalking is a subreddit that focuses upon presenting information about predatory gangstalking and also to exist as a community to organize as a group to spread awareness and education.
  12. [REDDIT] https://www.reddit.com/r/AlternativeHealth/comments/3o3sre/study_329_by_the_standards_of_the_time/
    19K subscribers in the AlternativeHealth community. Find how some diseases can be healed with alternative medicine, and share your experience with…
  13. [REDDIT] https://www.reddit.com/r/AskAcademia/comments/p40pl6/icmje_authorship_standards/ [archived]
    ICMJE criteria were, broadly, adopted by many medical journals (as well as many life science journals). An author should meet all criteria, and all people meeting all criteria should be an author. However, this is not "the law". It is a set of recommendations, and specifically re…
  14. [REDDIT] https://www.reddit.com/r/labrats/comments/yhzpha/authorship_requirements/ [archived]
    The ICMJE guidelines and other guidelines are only that - guidelines. The final decision to include or exclude someone from the author list rests with the person supervising the study i.e. the principal investigator.
  15. [REDDIT] https://www.reddit.com/r/Documentaries/comments/75e77t/paxil_study_329_2011_the_study_that_hid_childrens/ [archived]
    Paxil Study 329 (2011) The study that hid children's suicides in order to extend the patent of a drug. The story revealed by an inquisitive journalist with no training.
  16. [REDDIT] https://www.reddit.com/r/BeautyGuruChatter/comments/11eh64l/comprehensive_list_of_problematic_brandsbrand/ [archived]
    A friend asked me the other day if Jaclyn cosmetics was problematic bc she was at Ulta and liked the color story of one of her eyeshadow palettes. I told her not to bother with that brand and tried to find alternatives with a similar color story and quickly realized how many bran…

CROSS-REFERENCE

Study 329: Paroxetine Clinical Trial Data Suppression and Publication Bias — SHARES-EVENT (OUTGOING)STUDY 329: PAROXETINE CLI…Medical Writing Support Disclosure Guidelines for IRBs and Journals (1994-2001) — SHARES-ACTOR (INCOMING)MEDICAL WRITING SUPPORT D…ICMJE Data Sharing Recommendations and Study 329 ControversiesICMJE DATA SHARING RECOMMEN…THIS FILESHARES-EVENTSHARES-ACTOR